An overdose Reduction PlaN

Slides:



Advertisements
Similar presentations
Daliah Heller, PhD, MPH Assistant Commissioner
Advertisements

Cindy Powers Magrini, PharmD, BCPS
PERMEATING BORDERS OVERDOSE PREVENTION Summer Conference 2014 July 24, 2014 ACOPC Allegheny County Overdose Prevention Coalition Presents.
Project Coordinator Overdose Prevention Project, Prevention Point Pittsburgh Alice Bell, LCSW.
FUNDING OPPORTUNITIES. BACKGROUND New category of funding in the FY13 Harold Rogers Prescription Drug Monitoring Program Official title is “Category 3:
Strategies for Incorporating OD Prevention Into Your Work Eliza Wheeler Drug Overdose Prevention & Education (DOPE) Project Harm Reduction Coalition
Implementation in Ohio’s Regional Psychiatric Hospitals.
Naloxone (Narcan) A true opioid overdose antidote.
OVERDOSE SOLUTIONS 2013 PROJECT LIFE LINE AN ACOPC INITIATIVE Sherry Rickard-Aasen.
Rx for Success Next Steps to Prevent Prescription Drug Abuse Rebecca Hebner, MPH Substance Abuse Prevention Systems Coordinator.
Baltimore Buprenorphine Initiative Advancing Recovery Project Baltimore City, Maryland January 14, 2010.
Origin and Process of Utah Guidelines Anna Fondario, MPH Utah Department of Health Violence and Injury Prevention Program.
Naloxone: Cost, Logistics, and Supply Issues Community Pharmacy Perspective Krystalyn Weaver, PharmD National Alliance of State Pharmacy Associations.
1 December 8, 2015 Crista M. Taylor, LCSW-C Director, Information, Planning and Development Adrienne Breidenstine, MSW Director of Opioid Overdose Prevention.
The Impact on Caregivers of Young Adult Opioid Use Sarah Bagley MD Addiction Medicine Fellow Clinical Addiction Research and Education Unit Boston University.
Overdose Prevention Pilot Project Cross Systems Collaboration. Naloxone Distribution In cooperation with LA Community Health Project June 4, 2014, VCBH,
ASTHO Prescription Drug Misuse and Abuse Strategic Map:
Nebraska’s Prescription Drug Monitoring Program What Do I Really Need to Know? Amy Reynoldson, DHHS Kevin C. Borcher, PharmD,NeHII, Inc.
Pennsylvania Department of Health Division of Immunizations.
The AMA: Reducing Opioid Abuse in America Patrice A. Harris, MD, MA Board Chair American Medical Association September 2016.
HOPE Agenda Heroin, Opioid Prevention & Education WISCONSIN STATE REPRESENTATIVE JOHN NYGREN – ASSEMBLY DISTRICT 89.
Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Pennsylvania's Prescription Drug Monitoring Program (PDMP) May 17, 2016.
Oregon Prescription Drug Monitoring Program
Pharmacist Role in Naloxone Prescribing
State Targeted Response to Opioid Crisis
Integrating Hepatitis into the World of Community Planning
Opioid Management in Primary Care Michael Parchman, MD, MPH
New NC Medical Board Opioid Prescribing CME Requirements
Nebraska Prescription Drug Overdose Prevention Program Efforts
Neonatal Abstinence Syndrome (NAS) Program Overview
COLLECTIVE IMPACT APPROACH TO ADDRESSING
Enhanced Pharmacy Provision in Edinburgh:
MacColl Center for Health Care Innovation
Script Your Future Adherence Challenge
OPIOID SAFETY. Indiana Statistics In Summary… About 100 Hoosiers die from drug overdoses every month, many from opioids such as heroin and prescription.
Opioid Crisis A Call to ACTION
Experiences from a national overdose prevention strategy: Nasal naloxone distribution and lessons learned Philipp Lobmaier, MD, PhD Norwegian Centre.
An Overview of the ePDMP
Addiction and the Opioid Crisis: HHS Update
ROOM project Addressing the Opioid Epidemic in the U.P.
Tackling the U.S. opioid crisis using blockchain
The Overdose Epidemic in RI:
A State Targeted Response to the Opioid Crisis:
Opioid Focus & Membership Has Its Privileges
MDHHS Response to the Opioid Crisis
The Opioid Epidemic: Coordinating a Municipal Response
Opiate Roundtable March 29, 2018 Karen Burgess, MD
Opioids in Butte County
Review why we’re doing this work Display survey results
Opioid-related harms and responses
As we reflect on policies and practices for expanding and improving early identification and early intervention for youth, I would like to tie together.
“Improving whole of health outcomes for adults with severe mental illness in Lismore” A partnership project ( ) between people with a lived experience.
Pain Management and Substance Use Disorders: JCPP Strategic Session
Using Data to Combat the Opioid Overdose Crisis
Ten Pearls for Medication Assisted Treatment of Opiate Use Disorders
The Overdose Epidemic in RI:
NJ Cares Initiatives Impact on Municipalities
German Drug and Addiction Policy
Do Well by Doing Good: Expand the Connecticut Prescription Monitoring and Reporting System (CPMRS) Amy C. Justice MD, PhD Professor of Medicine and Public.
Naloxone in North Carolina
Town of Collingwood Council September 10th, 2018 Mia Brown RN BScN
Rebecca Snead Executive Vice President & CEO NASPA
2018 Prescription Nation Report
Meeting Agenda for 3/28/19 1) Check-in – Positive Focus
Community-Based Strategies for Preventing Opioid Abuse
Strategic Initiatives to Address Opioid Overdose & Addiction
Medication Assisted Treatment of Opioid Use Disorder
Addiction Prevention Services
Projects and partial aim statements
March 8, 2006 New ACIP Hepatitis B Recommendations
Presentation transcript:

An overdose Reduction PlaN Prevention Point Philadelphia

Our Mission PPP is a non-profit, public health organization committed to protecting the health and welfare of drug users and sex workers. PPP works to reduce the harm associated with substance use and sex Industry work by offering a safe and humane alternative to the war on drugs. Our Mission

Penn's National Clinician Scholars Program 2016-2018 Cohort [ ] add back in background and agenda slides

Background: Opiate Epidemic in Philadelphia Revise this slide

Background: Naloxone Naloxone (aka narcan): prescription medication that blocks effects of opioids and can reverse overdose Available intranasal or injectable form Free w/ Medicaid but can cost in the $1,000s out of pocket Shelf-life is 18-24 months Goal: distribute naloxone to users, caregivers, family members, first responders to reverse overdose in the community Intranasal and injectable forms

Provider training in naloxone prescribing is effective. Four Key Lessons Public and community-based organizations should be integrated into opiate reduction efforts. People who use drugs (PWUD) want to use naloxone, but face barriers to access. Pharmacies don’t know about the standing order and if they do, they misunderstand. Provider training in naloxone prescribing is effective. Pharmacies don’t know about the standing order and if they do, they misunderstand. People who use drugs (PWUD) want to use naloxone, but face barriers to access. 1 2 Public and community-based organizations should be integrated into opiate reduction efforts. Provider training in naloxone prescribing is effective. 3 4

Lesson #1 Pharmacies don’t know about the standing order and if they do, they misunderstand.

Pennsylvania Standing Order October 2015, PA Surgeon General Rachel Levine signed PA standing order “Non-patient specific” prescribing Third-party prescribing Standing order is voluntary & pharmacists are not required to have naloxone in stock

Pharmacy Awareness of Standing Order by Zip Code Lesson #1: Pharmacists Pharmacy Awareness of Standing Order by Zip Code Total answering question = 85 pharmacies 6 did not know [ ] change back to bar chart slide 35 Yes (41%) 44 had not heard (51%)

Is a prescription needed to dispense Naloxone? Lesson #1: Pharmacists Is a prescription needed to dispense Naloxone? n = 61 Don’t Know 26% Yes 53% No 21%

1 of 8 Lesson #1: Pharmacists Pharmacies had naloxone in stock AND will dispense without a prescription. [ ] explain why in the highest OD area, there are so few pharmacies that are aware of the standing order

Lesson #1: Pharmacists Pharmacies don’t know about the standing order and if they do, they misunderstand. Deliver a naloxone toolkit to pharmacies in targeted zip codes before expanding city-wide Implement widespread pharmacy teaching by partnering with pharmacy professional associations, city/state health commissions, and pharmacist champions, with options for continuing education credits Create a serial data collection protocol to monitor uptake of standing order amongst pharmacies in high-risk areas [ ] add in pharmacy association [ ] PA physician general [ ] Philadelphia Health Commissioner [ ] Pharmacy Association [ ] pharmacy-based credits

Lesson #2 People who use drugs (PWUD) want to use naloxone, but face barriers to access. There’s low but increasing awareness of overdose risk, cost and pharmacy access Pwud need: 1) naloxone 2) safe site etc

Lesson #2: People Who Use Drugs People who use drugs want to use naloxone, but face barriers to access Educate users that Medicaid recipients can obtain Naloxone from pharmacies for free Develop strategies for Medicaid recipients to store/replicate insurance cards and IDs in order to receive free Narcan from pharmacies Increase insurance enrollment among people who use drugs Support existing drop-in harm reduction services to ensure secure, safe environments for drug users [ ] add in pharmacy association [ ] PA physician general [ ] Philadelphia Health Commissioner [ ] Pharmacy Association [ ] pharmacy-based credits

Lesson #3 Public and community-based organizations (CBOs) should be integrated into opiate reduction efforts.

Lesson #3: Public & CBOs General public has little knowledge of overdose deaths Mass media campaigns and neighborhood-based solutions are needed Model CBO Opioid Overdose Prevention Programs Baltimore Crisis Response - Mobile Crisis Team New York State Opioid Overdose Prevention Program Registry

Lesson #3: Public & CBOs Public and community-based organizations should be integrated into opiate reduction efforts. Secure immediate and long-term, sustainable funding to purchase naloxone Apply lessons from mass media public health campaigns (i.e. HIV), targeting not just users, but also pain patients, caregivers, families, and the general public Identify CBOs that are willing to distribute naloxone and coordinate with existing opiate reduction organizations [ ] add in pharmacy association [ ] PA physician general [ ] Philadelphia Health Commissioner [ ] Pharmacy Association [ ] pharmacy-based credits

Provider training in naloxone prescribing is effective. Lesson #4 Provider training in naloxone prescribing is effective.

Lesson #4: Providers Coffin et. al, Ann Intern Med, 2016 Aug 16;165(4):245-52

Lesson #4: Providers “If you have someone on chronic opioids, it is useful to co-prescribe naloxone.” --Stakeholder

Provider training in naloxone prescribing is effective. Lesson #4: Providers Provider training in naloxone prescribing is effective. Develop mandatory, multi-modal training models on co-prescribing and PDMP to all providers, including nurses, physicians, and trainees Implement mandatory training on opiate reversal and increase access to naloxone for first responders Collect and monitor prescribing patterns by advocating for EHR and PDMP interoperability [ ] add in pharmacy association [ ] PA physician general [ ] Philadelphia Health Commissioner [ ] Pharmacy Association [ ] pharmacy-based credits

This is a multifaceted issue - framing is important! Tying It All Together This is a multifaceted issue - framing is important!

Provider training in naloxone prescribing is effective. Tying It All Together Pharmacies don’t know about the standing order and if they do, they misunderstand. People who use drugs (PWUD) want to use naloxone, but face barriers to access. 1 PEOPLE WHO USE DRUGS 2 PHARMACIES Public and community-based organizations should be integrated into opiate reduction efforts. Provider training in naloxone prescribing is effective. 3 4 PUBLIC PROVIDER

4-P Strategy for Opioid Overdose Reduction PEOPLE WHO USE DRUGS PHARMACIES PUBLIC PROVIDER

Questions Jose A. Benitez Executive Director Prevention Point Philadelphia 215-461-1710 jose@ppponline.org Questions